Skip to main
RGNT

RGNT Market Capitalization Overview

Market Cap: $34.29M as of Jan 9, 2026

$34.29M
$2.69M (7.26%)past month
As of Jan 9, 2026, RGNT has a market capitalization of $34.29M. Over the past 30 days, its market cap has decreased by -11.48%, while in the last 12 months, it has decreased by -1.78%.

Market capitalization represents the total value of Regentis Biomaterials Ltd. as perceived by the stock market. It is calculated by multiplying the current stock price by the total number of outstanding shares.

RGNT Market Cap Formula = Stock Price * Shares Outstanding

The market cap of RGNT helps investors assess the company's size and compare it with competitors for better investment decisions.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

RGNT Market Cap History

DateMarket CapChange
Dec 3, 2025$39.44M

RGNT End of Year Market Cap History

DateMarket CapChange
2026$34.29M-1.78%
2025$34.91M

FAQs About Regentis Biomaterials Ltd. (RGNT) Market Cap

As of Jan 9, 2026, the market capitalization of RGNT is $34.29M. Market cap represents the total value of a company’s outstanding shares and is a key indicator of its size in the stock market.

In the last 30 days, Regentis Biomaterials Ltd.’s market capitalization has decreased by -7.26%, changing from $36.98M to $34.29M as of Jan 9, 2026.

In the last 3 months, Regentis Biomaterials Ltd.’s market capitalization has increased by —, changing from – to – as of –.

In the year 2025, Regentis Biomaterials Ltd.’s market capitalization increased from – in January to $34.91M in December, reflecting a — change.

Regentis Biomaterials Ltd. (RGNT)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.